Rafferty Asset Management, LLC Spectrum Pharmaceuticals Inc Transaction History

Rafferty Asset Management, LLC

  • $28.9 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022
SELL
$1.27 - $2.42 $876,769 - $1.67 Million
-690,370 Closed
0 $0
Q3 2021

Nov 10, 2021
BUY
$2.15 - $3.82 $705,389 - $1.25 Million
328,088 Added 90.56%
690,370 $1.51 Million
Q2 2021

Aug 10, 2021
SELL
$2.89 - $4.45 $641,452 - $987,704
-221,956 Reduced 37.99%
362,282 $1.36 Million
Q1 2021

May 10, 2021
BUY
$2.9 - $4.09 $1.43 Million - $2.01 Million
491,733 Added 531.57%
584,238 $1.91 Million
Q4 2020

Feb 10, 2021
SELL
$3.38 - $5.14 $47,292 - $71,918
-13,992 Reduced 13.14%
92,505 $315,000
Q3 2020

Nov 13, 2020
BUY
$2.99 - $4.9 $152,439 - $249,816
50,983 Added 91.84%
106,497 $435,000
Q2 2020

Aug 07, 2020
BUY
$2.11 - $3.38 $117,134 - $187,637
55,514 New
55,514 $188,000
Q1 2020

May 15, 2020
SELL
$1.83 - $3.45 $154,020 - $290,365
-84,164 Closed
0 $0
Q4 2019

Feb 10, 2020
SELL
$3.5 - $10.35 $139,212 - $411,671
-39,775 Reduced 32.09%
84,164 $306,000
Q3 2019

Nov 14, 2019
SELL
$7.03 - $9.7 $372,934 - $514,575
-53,049 Reduced 29.97%
123,939 $1.03 Million
Q2 2019

Aug 09, 2019
SELL
$7.36 - $11.26 $142,754 - $218,398
-19,396 Reduced 9.88%
176,988 $1.52 Million
Q1 2019

May 15, 2019
BUY
$9.08 - $11.84 $1.78 Million - $2.33 Million
196,384 New
196,384 $2.1 Million

Others Institutions Holding SPPI

# of Institutions
1
Shares Held
115K
Call Options Held
0
Put Options Held
0
View Full List

About SPECTRUM PHARMACEUTICALS INC

SPPI Quotes by TradingView
  • Ticker SPPI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,164,000
  • Description
  • Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...
More about SPPI
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email